The anti-SARS-CoV-2 activity of novel 9, 10-dihydrophenanthrene derivatives : an insight into molecular docking, ADMET analysis, and molecular dynamics simulation
© 2023 The Authors. Published by Elsevier B.V..
Originating in Wuhan, the COVID-19 pandemic wave has had a profound impact on the global healthcare system. In this study, we used a 2D QSAR technique, ADMET analysis, molecular docking, and dynamic simulations to sort and evaluate the performance of thirty-nine bioactive analogues of 9,10-dihydrophenanthrene. The primary goal of the study is to use computational approaches to create a greater variety of structural references for the creation of more potent SARS-CoV-2 3Clpro inhibitors. This strategy is to speed up the process of finding active chemicals. Molecular descriptors were calculated using 'PaDEL' and 'ChemDes' software, and then redundant and non-significant descriptors were eliminated by a module in 'QSARINS ver. 2.2.2'. Subsequently, two statistically robust QSAR models were developed by applying multiple linear regression (MLR) methods. The correlation coefficients obtained by the two models are 0.89 and 0.82, respectively. These models were then subjected to internal and external validation tests, Y-randomization, and applicability domain analysis. The best model developed is applied to designate new molecules with good inhibitory activity values against severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). We also examined various pharmacokinetic properties using ADMET analysis. Then, through molecular docking simulations, we used the crystal structure of the main protease of SARS-CoV-2 (3CLpro/Mpro) in a complex with the covalent inhibitor "Narlaprevir" (PDB ID: 7JYC). We also supported our molecular docking predictions with an extended molecular dynamics simulation of a docked ligand-protein complex. We hope that the results obtained in this study can be used as good anti-SARS-CoV-2 inhibitors.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Scientific African - 21(2023) vom: 28. Sept., Seite e01754 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yamari, Imane [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ADMET |
|---|
| Anmerkungen: |
Date Revised 20.06.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.sciaf.2023.e01754 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358339251 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358339251 | ||
| 003 | DE-627 | ||
| 005 | 20231226074530.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.sciaf.2023.e01754 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1194.xml |
| 035 | |a (DE-627)NLM358339251 | ||
| 035 | |a (NLM)37332393 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yamari, Imane |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The anti-SARS-CoV-2 activity of novel 9, 10-dihydrophenanthrene derivatives |b an insight into molecular docking, ADMET analysis, and molecular dynamics simulation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Authors. Published by Elsevier B.V. | ||
| 520 | |a Originating in Wuhan, the COVID-19 pandemic wave has had a profound impact on the global healthcare system. In this study, we used a 2D QSAR technique, ADMET analysis, molecular docking, and dynamic simulations to sort and evaluate the performance of thirty-nine bioactive analogues of 9,10-dihydrophenanthrene. The primary goal of the study is to use computational approaches to create a greater variety of structural references for the creation of more potent SARS-CoV-2 3Clpro inhibitors. This strategy is to speed up the process of finding active chemicals. Molecular descriptors were calculated using 'PaDEL' and 'ChemDes' software, and then redundant and non-significant descriptors were eliminated by a module in 'QSARINS ver. 2.2.2'. Subsequently, two statistically robust QSAR models were developed by applying multiple linear regression (MLR) methods. The correlation coefficients obtained by the two models are 0.89 and 0.82, respectively. These models were then subjected to internal and external validation tests, Y-randomization, and applicability domain analysis. The best model developed is applied to designate new molecules with good inhibitory activity values against severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). We also examined various pharmacokinetic properties using ADMET analysis. Then, through molecular docking simulations, we used the crystal structure of the main protease of SARS-CoV-2 (3CLpro/Mpro) in a complex with the covalent inhibitor "Narlaprevir" (PDB ID: 7JYC). We also supported our molecular docking predictions with an extended molecular dynamics simulation of a docked ligand-protein complex. We hope that the results obtained in this study can be used as good anti-SARS-CoV-2 inhibitors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ADMET | |
| 650 | 4 | |a Dihydrophenanthrene | |
| 650 | 4 | |a Molecular docking | |
| 650 | 4 | |a Molecular dynamics | |
| 650 | 4 | |a QSAR | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Abchir, Oussama |e verfasserin |4 aut | |
| 700 | 1 | |a Mali, Suraj N |e verfasserin |4 aut | |
| 700 | 1 | |a Errougui, Abdelkbir |e verfasserin |4 aut | |
| 700 | 1 | |a Talbi, Mohammed |e verfasserin |4 aut | |
| 700 | 1 | |a Kouali, Mhammed El |e verfasserin |4 aut | |
| 700 | 1 | |a Chtita, Samir |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Scientific African |d 2020 |g 21(2023) vom: 28. Sept., Seite e01754 |w (DE-627)NLM315662530 |x 2468-2276 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2023 |g day:28 |g month:09 |g pages:e01754 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.sciaf.2023.e01754 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2023 |b 28 |c 09 |h e01754 | ||